>

LABORATORIO Stock Today

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>LA</div>
LABORATORIO REIG has more than 61 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 30 days. Equity ratings for LABORATORIO REIG JOFRE S A are calculated based on the Macroaxis scoring framework. The performance scores are derived for the period starting the 11th of January 2020 and ending today, the 10th of April 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores
LABORATORIO REIG JOFRE S A cannot be verified against its exchange. Apparently, LABORATORIO REIG is not available for investing at the moment. Please verify the symbol is currently traded on Madrid SE C.A.T.S.. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

LABORATORIO REIG Profile

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and nutritional supplements. Laboratorio Reig Jofre, S.A. was founded in 1929 and is based in Barcelona, Spain. LABORATORIO REIG operates under Drug Manufacturers - Specialty Generic classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 1000 people.. The public information regarding LABORATORIO REIG JOFRE S A's current market price is not available at this time.
Legal NameLABORATORIO REIG JOFRE S A
Thematic Classification
Currently Active Investing Idea
  Healthcare
View All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
LABORATORIO REIG JOFRE S A (RJF) is traded on Madrid SE C.A.T.S. in Spain and employs 1,000 people. The company currently falls under 'Small-Cap' category with current market capitalization of 179.16 M. LABORATORIO REIG JOFRE operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 75.59 M outstanding shares. The company has accumulated about 33.99 M in cash with 20.69 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Check LABORATORIO REIG Probability Of Bankruptcy

LABORATORIO Stock Against Markets

LABORATORIO REIG JOFRE S A cannot be verified against its exchange. Apparently, LABORATORIO REIG is not available for investing at the moment. Please verify the symbol is currently traded on Madrid SE C.A.T.S.. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

Check out Your Equity Center. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page